D-838-2013 Class I Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-838-2013 was initiated by Zydus Pharmaceuticals USA Inc on May 13, 2013 and is designated Class I. Reason for recall: Failed Tablet/Capsule Specifications: A product complaint was received from a pharmacist who discovered that 3 tablets in a 1000-count bottle were oversized. The recall status is terminated (terminated May 5, 2015). Affected quantity: 960 Bottles.

Recall details

Product Type
Drugs
Report Date
Aug 14, 2013
Initiation Date
May 13, 2013
Termination Date
May 5, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
960 Bottles

Product description

Warfarin Sodium Tablets, USP 2 mg, Rx Only, 1000 Tablets per bottle, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-053-10

Reason for recall

Failed Tablet/Capsule Specifications: A product complaint was received from a pharmacist who discovered that 3 tablets in a 1000-count bottle were oversized.

Distribution pattern

Nationwide

Code information

Lot MM5767

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-838-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-838-2013. Report a data issue: hello@regdatalab.com.